Statistics for Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study
Total visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study | 1 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya....pdf | 13 |